RxDoctor Payments Data

Steven Hughes, MD

Orthopaedic Surgery · McLean, VANPI 1255349148

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $75,012 of the $89,325 with a category attached, or 84.0%. Globus Medical accounts for 94.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $23,946, 4.2 times the $5,767 reported in 2019. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$89,325in general payments, 2019–2025

Across 52 payments — averaging $1717.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$84K
  • Arteriocyte Medical Systems, Inc.$5K
  • Boston Scientific$89
  • Medtronic$63
  • Supreme Orthopedic Systems, LLC$56
  • Amgen$16

What the payments were for

  • Royalty or licence$75,01284%
  • Consulting fees$8,0509%
  • Speaking & faculty fees$3,5004%
  • Travel & lodging$1,8402%
  • Food & beverage$9241%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$89,325 in reported general payments places this provider in the 90th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$320,385
Medicare patients
631
Services billed
1,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl34$163
Methylprednisolone26$158

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in McLean

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →